STONKWHISPER
← Back to Intel
Insider ActivityHALO

Torley Helen, PRESIDENT AND CEO, Director at HALOZYME THERAPEUTICS, INC., sold $425K of HALO

Updated Jun 19, 2026
Torley Helen PRESIDENT AND CEO, Director
HALOZYME THERAPEUTICS, INC. · $HALO
$425K Total Value
6,100 Shares Traded
$69.692 Price / Share
767,780 Shares Owned After
2026-06-03 Filing Date

Transaction Details

InsiderTorley Helen
TitlePRESIDENT AND CEO, Director
CompanyHALOZYME THERAPEUTICS, INC.
TickerHALO
Transaction TypeSale
Transaction Date2026-06-03
Shares Traded6,100
Price Per Share$69.692
Total Value$425K
Filed Date2026-06-03
Accession Number0001159036-26-000074

Ownership Context

Shares Owned After Transaction767,780
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001159036-26-000074

Other Insider Trades — HALO

Other Trades by Torley Helen

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for HALO — HALOZYME THERAPEUTICS, INC. →

Whisper Score — HALO

28.05
Murmurs
Current Whisper Score

See full analysis for HALO →

Track HALO insider activity in real time on The Wire →

Get alerts when Torley Helen files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 19, 2026 at 07:04 UTC

Want real-time data? Access The Wire for live sentiment tracking.